3557 results for «223»
3557 results
The five most impactful trials of 2024
19 Dec 2024 – From GulfPCR-GIM 2024
Stay ahead of the curve by exploring the five most impactful cardiovascular intervention trials of 2024. Gain insights into the latest evidence that can transform your clinical practice. Analyze the methodology and applicability of these groundbreaking studies, and learn how to seamlessly integrate them into your...
Mechanical circulatory support: role in the management of high-risk PCI and AMI-cardiogenic shock
19 Dec 2024 – From GulfPCR-GIM 2024
This session highlights the essential role of mechanical circulatory support (MCS) in managing high-risk PCI and AMI-related cardiogenic shock. Explore case-based discussions on device selection, hemodynamic impact, and evidence-based strategies to optimize outcomes in complex scenarios.
Management of coronary aneurysms
18 Dec 2024 – From GulfPCR-GIM 2024
Explore this session to discover innovative approaches to the management of complex coronary aneurysms. From contrast-induced nephropathy prevention using a balloon angiography system to rescue techniques for wire fracture during atherectomy, you'll gain insights into navigating challenging scenarios. Dive deeper into the percutaneous exclusion of a...
Training and well-being: how to make the cathlab an attractive place to work
19 Dec 2024 – From GulfPCR-GIM 2024
Discover strategies to transform the cath lab into an attractive and rewarding work environment. This session delves into the crucial aspects of training new colleagues and cultivating a positive well-being culture. Learn effective techniques to onboard and develop your team, ensuring they not only excel in...
Challenging structural interventions #2
19 Dec 2024 – From GulfPCR-GIM 2024
Explore this session on challenging structural interventions, covering critical topics such as when to transition from the cath lab to the operating room, considerations around post-dilation when performing valve-in-valve procedures, strategies for preventing complications in TAVI for bicuspid aortic valve and coarctation of the aorta, as...
Align for the future with Myval THV series - From randomised trials to everyday clinical practice
19 Dec 2024 – From GulfPCR-GIM 2024
Stay ahead in TAVI innovation by exploring the advanced balloon-expandable Myval THV series. This session highlights the latest clinical data, optimal sizing and implantation techniques, and valuable real-world insights, including long-term follow-up results.
Renal denervation in 2024
19 Dec 2024 – From GulfPCR-GIM 2024
Join us to explore advancements in renal denervation (RDN) technology and clinical applications. This session covers radiofrequency and ultrasound approaches, mechanisms, step-by-step procedures, patient selection, and program setup, offering insights into optimizing outcomes for hypertension patients.
Please note that this Case-in-a-Box does not reflect the recording standards...
When complications storm through the cathlab #2
19 Dec 2024 – From GulfPCR-GIM 2024
Brace yourself as we delve into a captivating session showcasing a series of complex and challenging complications that can arise in the catheterization laboratory. From a coiling gone awry to a stuck burr in an elderly patient, this session offers invaluable insights and strategies for navigating...
Interventional pot pourri #2
19 Dec 2024 – From GulfPCR-GIM 2024
This interventional potpourri session covers a diverse range of challenging cases in interventional cardiology. From a case of failed balloon angioplasty in a non-dilatable calcified lesion to an innovative approach for treating isolated side branch osteal lesions, this session offers valuable insights and practical solutions. Discover...
Complex non left main bifurcation PCI - LIVE case
19 Dec 2024 – From GulfPCR-GIM 2024
A 71-year-old male presented with angina (CCS 2), normal left ventricular function, and mitral stenosis. Coronary angiography revealed severe ostial stenosis of the circumflex artery and a significant LAD/diagonal bifurcation lesion (Medina 0.1.1).
The operators performed balloon valvuloplasty to treat the mitral stenosis, followed by LAD/diagonal PCI....
CTO PCI
19 Dec 2024 – From GulfPCR-GIM 2024
Embark on a journey to master Chronic Total Occlusion (CTO) Percutaneous Coronary Intervention (PCI) procedures. This comprehensive session will prepare your mindset, equip you with strategies to avoid failure, and provide valuable insights from real-world CTO case failures. Explore techniques to effectively deal with CTO procedure...
Fostering patient care with calcium management solution
18 Dec 2024 – From GulfPCR-GIM 2024
This sponsored session by Abbott explores the value of intracoronary imaging in managing calcified lesions. Learn how to adopt appropriate procedural strategies, utilize orbital atherectomy for plaque modification, and optimize stent results through the insights gained from a live case presentation and debriefing. Discover how these...
Align for the future with Myval THV series and complex PCI solutions
18 Dec 2024 – From GulfPCR-GIM 2024
Explore the future of complex PCI with Meril Life’s advanced solutions. Learn about thin-strut platforms, dedicated stents for side branches and diffuse lesions, the role of drug-eluting balloons in metal-free PCI, and the clinical potential of the Myval THV technology.
First-in-man randomised comparison of the Angiolite durable fluoroacrylate polymer-based sirolimus-eluting stent vs a durable fluoropolymer-based everolimus-eluting stent in patients with CAD: the ANGIOLITE trial
14 Jan 2020
The durable fluoroacrylate polymer-based sirolimus-eluting stent (Angiolite SES) has shown promising preclinical and clinical results regarding inflammatory vascular reaction and neointimal healing. J. Moreu, et al. aimed to compare performance between the Angiolite SES and an everolimus-eluting stent (EES) in patients with coronary artery disease.
Authors :
5-year outcomes after transcatheter or surgical aortic valve replacement in low-risk patients with aortic stenosis (Evolut Low Risk)
01 Apr 2025
Yohei Ohno provides his takeaways from the results of the Evolut Low Risk trial which was presented by Michael J. Reardon during the ACC.25 in Chicago.
Author
Does metallic stent ablation by rotational atherectomy influence on the coronary microcirculation?
09 Jul 2019
An 80-year-old man underwent percutaneous coronary intervention with a bare-metal stent for severe stenosis at proximal left anterior descending coronary artery 13 years ago. In-stent restenosis was treated by a drug-eluting stent 1 year later...
On-site computed tomography-derived fractional flow reserve to guide the management of patients with stable coronary artery disease: The TARGET randomized trial
05 Mar 2023
Mirvat Alasnag provides her take on this clinical trial presented by Yundai Chen at the American College of Cardiology Scientific Session (ACC.23/WCC).
Author
